Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)
Clinical trial NCT04882228 · UNKNOWN
Trial details
- NCT number
- NCT04882228
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2022-02-28
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.